Parallel Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.6K | Buy |
527
+111
| +27% | +$3.07K | ﹤0.01% | 2312 |
|
|
2025
Q1 | $9.24K | Hold |
416
| – | – | ﹤0.01% | 2450 |
|
|
2024
Q4 | $8.23K | Sell |
416
-105
| -20% | -$2.08K | ﹤0.01% | 2454 |
|
|
2024
Q3 | $13K | Hold |
521
| – | – | ﹤0.01% | 2288 |
|
|
2024
Q2 | $9.73K | Buy |
521
+3
| +0.6% | +$56 | ﹤0.01% | 2315 |
|
|
2024
Q1 | $10.2K | Hold |
518
| – | – | ﹤0.01% | 2305 |
|
|
2023
Q4 | $9.09K | Sell |
518
-161
| -24% | -$2.82K | ﹤0.01% | 2323 |
|
|
2023
Q3 | $11.8K | Buy |
679
+42
| +7% | +$730 | ﹤0.01% | 2109 |
|
|
2023
Q2 | $8.97K | Buy |
637
+446
| +234% | +$6.28K | ﹤0.01% | 2216 |
|
|
2023
Q1 | $2.06K | Buy |
+191
| New | +$2.06K | ﹤0.01% | 2766 |
|
|
2022
Q1 | – | Sell |
-24
| Closed | – | – | 3118 |
|
|
2021
Q4 | $0 | Buy |
+24
| New | – | ﹤0.01% | 3190 |
|